Browsed by
Tag: Biotech Investment

Harvard Bio Lab Secures $39M PE Funding, Ushering in Novel Research Model

Harvard Bio Lab Secures $39M PE Funding, Ushering in Novel Research Model

Harvard Bio Lab Secures $39M PE Funding, Ushering in Novel Research Model İş Private Equity, a Turkish firm, has invested $39M in a Harvard genetics and metabolism lab led by Prof. Gökhan Hotamışlıgil. This funding will support the lab’s research and simultaneously seed a new biotech, Enlila, focused on developing metabolic disease therapies. The investment represents a potentially transformative model for academic research funding, particularly given recent federal funding cuts. İş PE will also provide undisclosed funding for promising drug…

Read More Read More

Harvard Research Lab Secures $39 Million Lifeline from Private Equity, Ushering in New Era of Funding

Harvard Research Lab Secures $39 Million Lifeline from Private Equity, Ushering in New Era of Funding

Harvard Research Lab Secures $39 Million Lifeline from Private Equity, Ushering in New Era of Funding Facing funding cuts, Harvard University’s genetics and metabolism research is receiving a major boost. İş Private Equity, a Turkish firm, has committed $39 million to a lab led by Professor Gökhan Hotamışlıgil at the T.H. Chan School of Public Health. This isn’t just a financial injection; it’s a groundbreaking partnership. The investment will not only support Professor Hotamışlıgil’s crucial research but also fuel the…

Read More Read More